Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Bee venom helps hair grow and may work better than some common treatments.

The study created a new method to test drugs that affect hormone processing in skin.

Testosterone reduces key molecules needed for early pregnancy in rats.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Metformin might help treat certain skin conditions, but more research is needed.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

A person with a specific gene mutation had extra teeth, unique jaw and hair features not seen before in this condition.

Higher levels of the DP2 receptor may lead to hair loss.

Rice bran mineral extract may help promote hair growth and prevent hair loss.